RR
INSIDER · ANTX · AN2 Therapeutics, Inc. · DIRECTOR
Readnour Robin Shane
Every open-market transaction filed under this name, Sep 3 to Sep 8.
Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$97K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 8 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 5,294 | $6.02 | $32K | −1.1% |
| Sep 8 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 4,725 | $6.02 | $28K | −1.1% |
| Sep 3 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 3,223 | $6.07 | $20K | −2.0% |
| Sep 3 | ANTX | AN2 Therapeutics, Inc. | Director | Sell | 2,877 | $6.07 | $17K | −2.0% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.